A RP-HPLC Method for the Analysis of Neostigmine Methylsulfate and Process-Related Impurities, Forced Degradation Studies, in the Injection Formulation

Neostigmine methylsulfate is an anticholinesterase agent and is clinically used for treating myasthenia gravis. It is also used for reversing nondepolarising neuromuscular blocking agents. Neostigmine methylsulfate may be administered by intravenous, intramuscular, or subcutaneous injection. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Parab, Manali, Shirsat, Vaishali A., Kodgule, Yogita M., Kodgule, Mandar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133865/
https://www.ncbi.nlm.nih.gov/pubmed/34054964
http://dx.doi.org/10.1155/2021/5570173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133865/
https://www.ncbi.nlm.nih.gov/pubmed/34054964
http://dx.doi.org/10.1155/2021/5570173

Ejemplares similares